US2022162070A1PendingUtilityA1

Systems and Methods for Generating Nitric Oxide

Assignee: THIRD POLE INCPriority: May 15, 2019Filed: Feb 14, 2022Published: May 26, 2022
Est. expiryMay 15, 2039(~12.8 yrs left)· nominal 20-yr term from priority
A61M 2205/3606A61M 2230/30A61M 16/127A61M 16/0051A61M 2209/088A61M 2205/505A61M 2230/50A61M 16/104A61M 2205/7545A61M 16/204A61M 16/162A61M 2205/6027A61M 2205/15A61M 2202/0275A61M 2205/3673A61M 2205/8212A61M 16/16A61M 2205/0227A61M 2230/06H05H 1/46B01D 53/0415A61M 2205/6063A61M 2205/07C01B 21/203A61M 16/122A61M 2016/1025A61M 2205/3372A61M 2230/63A61M 16/0875A61M 16/0808A43B 7/00A61M 16/10B01D 2257/404A61M 2205/587A61M 16/0666A61M 2205/3553A61P 11/00A61M 2240/00A61M 2205/3379A61M 2206/22A61M 16/024A61M 2205/7518A61M 16/0093A61M 2205/70A61M 2205/6054A61M 2205/586A61M 2230/65A43B 3/34A61M 2230/435A61M 2202/0208A43B 3/38A61M 16/22A61M 2205/14A61M 2205/18A61M 2205/3368A61M 2205/6009A61P 9/00A61M 16/0672H01J 37/32146B01D 2259/4533H01J 37/04A61M 2209/082A61M 16/101A61M 16/142A61M 2205/3365A61M 16/1075A61M 2205/8218A61M 2205/7536A61M 16/12A61M 16/0048A61M 2230/42A43B 7/147A61M 16/085A61M 2205/125A61M 2205/42A61M 16/0833A61M 16/209A61M 2205/52A61M 2205/6072A61M 2205/7527A61M 2205/8262A61M 2205/3334A61M 2230/432A61M 16/0066A61N 1/3904A61M 2205/3358A61M 16/161A61M 2206/14A61M 16/0891A61M 2205/3306A61M 2205/3317A61M 16/105A61M 2016/102A61M 2230/60A61M 16/1055A61M 2209/086A43B 17/00G16H 20/40A61M 2016/0021G16H 40/20A61M 2230/205A61M 2205/332A61M 11/00A61M 2016/1035A61M 2205/3592A61M 2205/3653A61M 2205/3375B01D 2253/102C01B 21/24C01B 21/20C01B 21/32
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods for generating nitric oxide are disclosed. A nitic oxide (NO) generation system includes at least one pair of electrodes configured to generate a product gas containing NO from a flow of a reactant gas; and a controller configured to regulate the amount of nitric oxide in the product gas produced by the at least one pair of electrodes by utilizing duty cycle values of plasma pulses selected from a plurality of discrete duty cycles to produce a target rate of NO production based on an average of discrete production rates associated with each of the plurality of discrete duty cycles.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A nitric oxide system, comprising:
 a plasma chamber configured to generate a product gas containing nitric oxide from a flow of a reactant gas; and   at least one controller configured to regulate the amount of nitric oxide in the product gas using one or more parameters as an input to the controller, the one or more parameters including information relating to at least one of the reactant gas, the product gas, and an inspiratory gas into which at least a portion of the product gas flows, the controller configured to provide one or more doses of nitric oxide for prevention of infection.   
     
     
         2 . The system of  claim 1 , wherein the one or more doses of nitric oxide has a concentration of at least 80 ppm. 
     
     
         3 . The system of  claim 1 , where in the one or more doses of nitric oxide has a concentration of 100 to 300 ppm. 
     
     
         4 . The system of  claim 1 , wherein the controller is configured to provide one or more doses over a period of time. 
     
     
         5 . The system of  claim 4 , wherein the one or more doses is delivered periodically over the period of time, 
     
     
         6 . The system of  claim 1 , wherein the infection is a respiratory or pulmonary infection. The system of  claim 1 , further comprising a nitric oxide delivery device for providing the dose of nitric oxide. 
     
     
         8 . The system of claim  7 , wherein the nitric oxide delivery device is selected from the group consisting of an inhaler, an ambulatory device, a ventilator, a CPAP machine, an oxygen concentrator, a nasal cannula, a face mask, a CPAP mask, an endotracheal tube, a manual ventilation device, a catheter, a tracheal catheter, a anaesthesia device, a Bilevel Positive Airway Pressure (BiPAP) machine, a non-invasive positive pressure ventilator (NIPPV), a nebulizer, an extracorporeal membrane oxygenation (ECMO), a bypass system, an automated CPR system, an oxygen delivery system, an and delivery circuit. 
     
     
         9 . The system of  claim 1 , wherein NO is delivered to a portion of the breath. 
     
     
         10 . The system of  claim 1 , wherein NO is delivered to the entire inspired volume (or breath). 
     
     
         11 . The system of  claim 10 , wherein the diluted concentration of NO within the breath is constant. 
     
     
         12 . A nitric oxide system, comprising:
 a plasma chamber configured to generate a product gas containing nitric oxide from a flow of a reactant gas; and   at least one controller configured to regulate the amount of nitric oxide in the product gas using one or more parameters as an input to the controller, the one or more parameters including information relating to at least one of the reactant gas, the product gas, and an inspiratory gas into which at least a portion of the product gas flows, the controller configured to provide a plurality of doses of nitric oxide over a period of time for reducing a risk of infection.   
     
     
         13 . The system of  claim 12 , wherein the one or more doses of nitric oxide has a concentration of at least 80 ppm. 
     
     
         14 . The system of  claim 12 , wherein the infection is a pulmonary infection. 
     
     
         15 . A nitric oxide system, comprising:
 a source of gas including nitric oxide for delivery to a patient; and   at least one controller configured to regulate the amount of nitric oxide delivered to the patient using one or more parameters as an input to the controller, the one or more parameters including information relating to at least one of the gas including nitric oxide and an inspiratory gas into which at least a portion of the gas including nitric oxide flows, the controller configured to provide a plurality of doses of nitric oxide over a period of time for reducing a risk of infection.   
     
     
         16 . A method of delivering nitric oxide comprising:
 executing, by a controller, a dosing strategy configured to prevent infection in a patient; and   controlling, by the controller, the amount of nitric oxide to deliver one or more doses of nitric oxide in an amount and a frequency to prevent infection.   
     
     
         17 . The method of  claim 16 , wherein the one or more doses of nitric oxide has a concentration of at least 80 ppm. 
     
     
         18 . The method of  claim 16 , where in the one or more doses of nitric oxide has a concentration of 100 to 300 ppm. 
     
     
         19 . The method of  claim 16 , wherein the controller is configured to provide one or more doses over a period of time. 
     
     
         20 . The method of  claim 19 , wherein the one or more doses is delivered periodically over the period of time. 
     
     
         21 . The method of  claim 16 , wherein the infection is a respiratory or pulmonary infection. 
     
     
         22 . The method of  claim 16 , further comprising controlling an amount of nitric oxide generated by an NO generator to produce a target amount of nitric oxide as in the dosing strategy. 
     
     
         23 . The method of  claim 16 , further comprising a nitric oxide delivery device for providing the dose of nitric oxide. 
     
     
         24 . The method of  claim 23 , wherein the nitric oxide delivery device is selected from the group consisting of an inhaler, an ambulatory device, a ventilator, a CPAP machine, an oxygen concentrator, a nasal cannula, a face mask, a CPAP mask, an endotracheal tube, a manual ventilation device, a catheter, a tracheal catheter, a anaesthesia device, a Bilevel Positive Airway Pressure (BiPAP) machine, a non-invasive positive pressure ventilator (NIPPV), a nebulizer, an extracorporeal membrane oxygenation (ECMO), a bypass system, an automated CPR system, an oxygen delivery system, and delivery circuit.

Join the waitlist — get patent alerts

Track US2022162070A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.